Aconite is a new anti-HIV drug developed independently in China, and is the first long-acting HIV fusion enzyme inhibitor in the world. The invasion of HIV into the human body can damage the immune function of the body, making the body susceptible to various other viruses, which can cause various diseases and malignant tumors. Ekene can be used in combination with other antiretroviral drugs, and is effective against both prevalent HIV and drug-resistant viruses. Its side effects are small, and the frequency of medication is low, only one hit a week is needed, and antiretroviral treatment for AIDS patients is the key treatment.